Impact of Brokerage Rating on TransEnterix, Inc.(TRXC)

Many TransEnterix, Inc.(TRXC) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Transenterix Inc was Downgraded by Raymond James to Mkt Perform on Jan 19, 2017.

Company has reported several Insider transactions to the SEC, on Jan 6, 2017, S.p.a Sofar, (10% owner) purchased 3,722,685 shares at 1.40 per share price.On Aug 23, 2016, Andrea Biffi (director) purchased 40,000 shares at 1.40 per share price.On Jun 15, 2016, Anthony C. J. Fernando (Chief Technology Officer) purchased 27,000 shares at 1.46 per share price.

TransEnterix, Inc. (NYSEMKT:TRXC) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.5 by 4 Brokerage Firm. 3 Wall Street Firms have rated the stock as a strong buys. 1 Brokerage Firms have advised hold.

TransEnterix, Inc. (NYSEMKT:TRXC): 3 analysts have set the short term price target of TransEnterix, Inc. (NYSEMKT:TRXC) at $3.58. The standard deviation of short term price target has been estimated at $0.52, implying that the actual price may fluctuate by this value. The higher and the lower price estimates are $ 4 and $3 respectively.

TransEnterix, Inc. (NYSEMKT:TRXC) rose 0.75% or 0.01 points on Tuesday and made its way into the gainers of the day. After trading began at $1.37 the stock was seen hitting $1.3769 as a peak level and $1.33 as the lowest level. The stock ended up at $1.35. The daily volume was measured at 697,123 shares. The 52-week high of the share price is $6.1 and the 52-week low is $1.03. The company has a market cap of $182 million.

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.


Share this post

Leave a Reply